Viewing articles in Portfolio:

Health

Filter Articles

Greens renew call for Drug Law Reform

Rachel Siewert 4 Mar 2021

The Australian Laywer’s Alliance "Doing More Harm Than Good: The need for a health-focused approach to drug use" report clearly shows that a national approach to harm minimisation is long overdue.  
 
"The legal and medical sectors have been saying for decades that treating drug use as a criminal matter, rather than a health issue does not work", Australian Greens Health spokesperson Senator Rachel Siewert said today. 
 

Read more

We need a new approach to quarantine

Rachel Siewert 17 Feb 2021

The Greens say quarantine facilities need to be established out of cities and that facilities must be publicly funded and run. 

“Our hotel quarantine system needs to be watertight. The UK, South Africa, Brazil variants are becoming the dominant variants in other parts of the world and we must keep these from getting out into our community”, Greens spokesperson on Health Senator Rachel Siewert said

Read more

Greens welcome AstraZeneca approval but say further diversity is needed. 

Rachel Siewert 16 Feb 2021

The Greens welcome the news that AstraZeneca has been provisionally approved by the Therapeutic Goods Administration for use in Australia.
 
“However we cannot put all our eggs in one basket. It’s clear with differing rates of efficacy and with new Covid-19 strains developing that we must continue to expand and diversify Australia’s vaccine portfolio”, Australian Greens spokesperson on Health Senator Rachel Siewert said.
 

Read more

South Africa's AstraZeneca suspension underlines urgency of local vaccine manufacture

The Greens say the suspension of the AstraZeneca vaccine roll-out in South Africa shows the need for the government to establish a publicly-owned mRNA vaccine manufacturer in Australia.

Australia needs to be nimble and able to quickly adapt vaccines to ever-mutating strains of COVID, which would only be possible with a local, publicly owned facility that puts health, not profits, first.

Leader of the Australian Greens Adam Bandt MP said:

Read more

Greens call for Government to diversify vaccines contracts and strategise for herd immunity 

Rachel Siewert 4 Feb 2021

The Greens say that the Government must continue to expand and diversify Australia’s vaccine portfolio immediately in light of the varying rates of effectiveness of vaccines against new strains. 
 
“We cannot rely on AstraZeneca as our only contingency plan - we need to have a diverse portfolio to rapidly pivot to deal with new strains, including securing deals with Moderna and more Pfizer doses", Greens spokesperson on Health Senator Rachel Siewert said. 
 

Read more

Publicly owned mRNA vaccine manufacturer needed

Adam Bandt 4 Feb 2021

The Greens have called for the government to establish a publicly-owned mRNA vaccine manufacturer in Australia, so that Australia can be guaranteed it will receive enough of the mRNA vaccines that are proving to be more effective and more adaptable as the virus mutates. 

Adam Bandt MP has commended scientists and health experts who have joined the Greens call for Australia to build its own domestic mRNA vaccine manufacturing capacity.

Leader of the Australian Greens Adam Bandt MP said:

Read more

Decades of manufacturing decline limits vaccine options, publicly-owned vaccine manufacturer could save lives

The Greens say that decades of decline in Australian manufacturing puts the nation at risk of having fewer options when it comes to Covid-19 vaccines, and have called for a publicly-owned vaccine manufacturer.

Both Pfizer/BioNTech and Moderna vaccines are based on new technology (mRNA), and while CSL has capacity to manufacture the protein based vaccines it doesn’t at this time have the ability to produce mRNA.

Read more